Empadus 25 mg (Tablet) contains Empagliflozin 25 mg. It is an SGLT2 inhibitor used to improve blood sugar control in adults with type 2 diabetes mellitus and to reduce the risk of cardiovascular and kidney complications in appropriate patients.
Uses:
Treatment of type 2 diabetes mellitus
Improves blood glucose control along with diet and exercise
Reduces the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease
Helps reduce the risk of hospitalization for heart failure
Helps slow the progression of chronic kidney disease (as prescribed)
Dose:
Adults: Usually 25 mg once daily or as directed by a physician.
Take the medicine exactly as prescribed by a healthcare professional.
It may be taken with or without food.
Maintain adequate hydration during treatment.
Dose and duration depend on the patient's blood glucose levels, kidney function, and response to treatment.